Showing 1 - 2 results of 2 for search 'Bunichiro Ogawa', query time: 0.02s
Refine Results
-
1
Unique structure of ozoralizumab, a trivalent anti-TNFα NANOBODY® compound, offers the potential advantage of mitigating the risk of immune complex-induced inflammation by Masanao Kyuuma, Ayaka Kaku, Chiemi Mishima-Tsumagari, Bunichiro Ogawa, Mayumi Endo, Yunoshin Tamura, Kei-ichiro Ishikura, Masashi Mima, Yutaka Nakanishi, Yasuyuki Fujii
Published 2023-04-01
Article -
2
A novel anti-TNF-α drug ozoralizumab rapidly distributes to inflamed joint tissues in a mouse model of collagen induced arthritis by Shohei Oyama, Kosuke Ebina, Yuki Etani, Makoto Hirao, Masanao Kyuuma, Yasuyuki Fujii, Katsuya Iwata, Bunichiro Ogawa, Tomoya Hasegawa, Sasagu Kawano, Yutaka Nakanishi, Seiji Okada, Ken Nakata
Published 2022-10-01
Article